| Approved on: | 2024-02-28 |
| Brief purpose of the study: | Investigate the effects of phosphatidylserine (PS) supplementation on vascular health in individuals with type 2 diabetes |
| Brief summary of what participants will be asked to do: | Attend 5 in-person study visits over the course of 2 months.
Take a supplement or placebo for 1 month. |
| Basic eligibility criteria: | -Diagnosis of Type 2 Diabetes
-Age 45-64
-BMI of 25-39 |
| Study contact for more information: | Katherine Burr (study coordinator): katherineburr@health.missouri.edu |
| IRB Number: | 2025921 MU |
